Literature DB >> 15805137

Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung.

Thomas G Brock1, Young-Jik Lee, Elana Maydanski, Tessa L Marburger, Ming Luo, Robert Paine, Marc Peters-Golden.   

Abstract

Leukotriene A4 (LTA4) hydrolase catalyzes the final step in leukotriene B4 (LTB4) synthesis. In addition to its role in LTB4 synthesis, the enzyme possesses aminopeptidase activity. In this study, we sought to define the subcellular distribution of LTA4 hydrolase in alveolar epithelial cells, which lack 5-lipoxygenase and do not synthesize LTA4. Immunohistochemical staining localized LTA4 hydrolase in the nucleus of type II but not type I alveolar epithelial cells of normal mouse, human, and rat lungs. Nuclear localization of LTA4 hydrolase was also demonstrated in proliferating type II-like A549 cells. The apparent redistribution of LTA4 hydrolase from the nucleus to the cytoplasm during type II-to-type I cell differentiation in vivo was recapitulated in vitro. Surprisingly, this change in localization of LTA4 hydrolase did not affect the capacity of isolated cells to convert LTA4 to LTB4. However, proliferation of A549 cells was inhibited by the aminopeptidase inhibitor bestatin. Nuclear accumulation of LTA4 hydrolase was also conspicuous in epithelial cells during alveolar repair following bleomycin-induced acute lung injury in mice, as well as in hyperplastic type II cells associated with fibrotic lung tissues from patients with idiopathic pulmonary fibrosis. These results show for the first time that LTA4 hydrolase can be accumulated in the nucleus of type II alveolar epithelial cells and that redistribution of the enzyme to the cytoplasm occurs with differentiation to the type I phenotype. Furthermore, the aminopeptidase activity of LTA4 hydrolase within the nucleus may play a role in promoting epithelial cell growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805137     DOI: 10.1152/ajplung.00423.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  7 in total

Review 1.  Location, location, location: compartmentalization of early events in leukotriene biosynthesis.

Authors:  Marcia E Newcomer; Nathaniel C Gilbert
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

2.  Expression of 5-lipoxygenase in specialized epithelial cells of nasopharyngeal-associated lymphoid tissue.

Authors:  Thomas G Brock
Journal:  J Mol Histol       Date:  2006-04-28       Impact factor: 2.611

3.  Substrate-dependent modulation of the leukotriene A4 hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammation.

Authors:  Kyung Hyeon Lee; Nadia Fazal Ali; Soo Hyeon Lee; Zhimin Zhang; Marie Burdick; Zachary J Beaulac; Greg Petruncio; Linxia Li; Jiangdong Xiang; Ezra M Chung; Kenneth W Foreman; Schroeder M Noble; Yun M Shim; Mikell Paige
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

4.  Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema.

Authors:  Mikell Paige; Kan Wang; Marie Burdick; Sunhye Park; Josiah Cha; Erin Jeffery; Nicholas Sherman; Y Michael Shim
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

5.  Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.

Authors:  A Koeberle; F Pollastro; H Northoff; O Werz
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

6.  Tannic acid alleviates experimental pulmonary fibrosis in mice by inhibiting inflammatory response and fibrotic process.

Authors:  Nandhine Rajasekar; Ayyanar Sivanantham; Amrita Kar; Santanu Kar Mahapatra; Rajesh Ahirwar; Rajesh K Thimmulappa; Sudhakar Gandhi Paramasivam; Rajasekaran Subbiah
Journal:  Inflammopharmacology       Date:  2020-05-05       Impact factor: 4.473

7.  Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.

Authors:  Jin Qian; Wen Tian; Xinguo Jiang; Rasa Tamosiuniene; Yon K Sung; Eric M Shuffle; Allen B Tu; Antonia Valenzuela; Shirley Jiang; Roham T Zamanian; David F Fiorentino; Norbert F Voelkel; Marc Peters-Golden; Kurt R Stenmark; Lorinda Chung; Marlene Rabinovitch; Mark R Nicolls
Journal:  Hypertension       Date:  2015-10-05       Impact factor: 10.190

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.